Table 1. Baseline Characteristics of Overall Sample of 4 039 216 Youths Aged 13 to 22 Years Stratified by Opioid Overdose, January 1, 2009, to September 30, 2015.
Characteristic | No. (%) of Youths by Column | P Value | |
---|---|---|---|
Without Opioid Overdose (n = 4 035 425) | With Opioid Overdose (n = 3791) | ||
Age at overdose, y | |||
13-15 | NA | 596 (15.7) | NA |
16-17 | NA | 880 (23.2) | |
18-20 | NA | 1542 (40.7) | |
21-22 | NA | 773 (20.4) | |
Sex | |||
Male | 1 937 963 (48.0) | 1557 (41.1) | <.001 |
Female | 2 097 462 (52.0) | 2234 (58.9) | |
Pregnanta,b | 425 949 (10.6) | 470 (12.4) | <.001 |
Race/ethnicity | |||
White non-Hispanic | 1 898 286 (47.0) | 2491 (65.7) | <.001 |
Black non-Hispanic | 1 352 276 (33.5) | 680 (17.9) | |
Hispanic | 255 525 (6.3) | 144 (3.8) | |
Other | 529 338 (13.1) | 476 (12.6) | |
Pain conditiona | |||
Acute | 1 622 752 (40.2) | 2242 (59.1) | <.001 |
Chronic | 1 479 933 (36.7) | 2070 (54.6) | <.001 |
Depressiona | 515 318 (12.8) | 2329 (61.4) | <.001 |
Self-harm/suicidal ideationa | 87 310 (2.2) | 1313 (34.6) | <.001 |
Anxiety disordera | 418 322 (10.4) | 1812 (47.8) | <.001 |
Attention-deficit/hyperactivity disordera | 510 871 (12.7) | 771 (20.3) | <.001 |
Use disordera | |||
Opioid | 14 481 (0.4) | 725 (19.1) | <.001 |
Alcohol | 50 917 (1.3) | 713 (18.8) | <.001 |
Other substance | 138 717 (3.4) | 1744 (46.0) | <.001 |
Prior pharmacotherapyc | NA | 85 (2.2) | NA |
Prior behavioral health servicesc | NA | 792 (20.9) | NA |
Prior opioid prescriptionc | NA | 849 (22.4) | NA |
Year of overdose | |||
2009 | NA | 305 (8.0) | NA |
2010 | NA | 355 (9.4) | |
2011 | NA | 325 (8.6) | |
2012 | NA | 493 (13.0) | |
2013 | NA | 475 (12.5) | |
2014 | NA | 1010 (26.6) | |
2015 | NA | 828 (21.8) |
Abbreviation: NA, not applicable.
During the 3 months prior and up to 1 month after receiving an opioid overdose diagnosis.
Percentage of all individuals in the sample.
During the 3 months prior to receiving an opioid overdose diagnosis.